|
|
Article: India's Breast Cancer Drug Market Will Almost Double by 2012.
- Article from:
- PR Newswire
- Article date:
- December 10, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Indian Physicians Start to Incorporate Targeted Therapies to Achieve Better Efficacy and Toxicity Profiles Than Conventional Therapies, According to a Report From Decision Resources
WALTHAM, Mass., Dec. 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the Indian breast cancer drug market will almost double from $35 million in 2007 to $64 million by 2012. According to the new Emerging Markets report entitled Breast Cancer in India, this growth will be fueled by rising disease prevalence, increasing wealth and growing disease awareness.
The report ...